cox 189 has been researched along with Acute Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adekunle, F; Andrews, C; Ellis, G; Kinch, H; Kyle, C; Zachariah, J | 1 |
| Derry, S; Moore, RA; Roy, YM | 1 |
| Ghiculescu, RA; Lampe, G; Macdonald, GA; Pillans, PI; Wilson, R; Wong, R | 1 |
| Mysler, E | 1 |
| Packman, B; Packman, E; Thurston, H; Tseng, L | 1 |
| Derbot, J; Jung, T; Krammer, G; Kreiss, A; Litschig, S; Mysler, E; Tate, GA; Thurston, H; Willburger, RE | 1 |
| Bannwarth, B; Bérenbaum, F | 1 |
| Chaves, MH; Cunha, GM; Holanda Pinto, SA; Pinto, LM; Rao, VS; Santos, FA | 1 |
3 review(s) available for cox 189 and Acute Disease
| Article | Year |
|---|---|
Single dose oral lumiracoxib for postoperative pain in adults.
Topics: Acute Disease; Administration, Oral; Adult; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Pain, Postoperative; Randomized Controlled Trials as Topic; Time Factors | 2010 |
Lumiracoxib (Prexige): a new selective COX-2 inhibitor.
Topics: Acute Disease; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Evaluation; Drug Interactions; Gastrointestinal Diseases; Humans; Isoenzymes; Membrane Proteins; Organic Chemicals; Pain; Prostaglandin-Endoperoxide Synthases | 2004 |
Lumiracoxib in the management of osteoarthritis and acute pain.
Topics: Acute Disease; Animals; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Approval; Humans; Osteoarthritis; Pain; Peptic Ulcer; Risk Assessment; Treatment Outcome | 2007 |
3 trial(s) available for cox 189 and Acute Disease
| Article | Year |
|---|---|
A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain.
Topics: Acute Disease; Adult; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Musculoskeletal Diseases; Naproxen; Pain; Treatment Outcome | 2008 |
Lumiracoxib is effective in the treatment of episodic tension-type headache.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Organic Chemicals; Tension-Type Headache; Treatment Outcome | 2005 |
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout.
Topics: Abdominal Pain; Acute Disease; Administration, Oral; Adult; Aged; Analysis of Variance; Argentina; Diclofenac; Double-Blind Method; Drug Administration Schedule; Female; Germany; Gout; Headache; Humans; Indomethacin; Joints; Logistic Models; Male; Middle Aged; Pain Measurement; Treatment Outcome; Vertigo | 2007 |
2 other study(ies) available for cox 189 and Acute Disease
| Article | Year |
|---|---|
Severe acute liver injury associated with lumiracoxib.
Topics: Acute Disease; Autoantibodies; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2 Inhibitors; Diclofenac; Fatal Outcome; Female; Humans; Liver Transplantation; Middle Aged; Osteoarthritis | 2012 |
Anti-inflammatory effect of alpha, beta-Amyrin, a pentacyclic triterpene from Protium heptaphyllum in rat model of acute periodontitis.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Burseraceae; Dexamethasone; Diclofenac; Disease Models, Animal; Gingiva; Gingivitis; Isomerism; Male; Molecular Structure; Neutrophil Infiltration; Oleanolic Acid; Oxidative Stress; Pentacyclic Triterpenes; Periodontitis; Peroxidase; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2008 |